80 likes | 86 Views
Patent Medicine Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
E N D
PATENT MEDICINE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Patent Medicine Market - Overview Global Patent Medicine Market - Regional Analysis. On the basis of region, the global Patent Medicine Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The North America patent medicine system is effective and attracts investments from companies who want profit from pharmaceutical industry. Pharmaceutical companies in the U.S. are investing in research and development of novel medicines. For instance, in July 2020, Pfizer Inc patented its substituted carbonucleoside derivatives useful as anticancer agents. Key players in region are Pfizer Inc and Bristol-Myers Squibb. A patent medicine, also known as Nostrum (our remedy), is a commercial product that is developed for the first time for a specific disease condition. It is initially sold under a brand name by which the physician can prescribe the drug for use of patients. Patent medicine is a concept, which means that only the pharmaceutical company that holds the patent is allowed to manufacture and make profit out of it. In most cases, drug patent is awarded for 20 years to pharmaceutical companies. Moreover, sometimes the period of patent for drug has different lifespan in years according to its utility and in the country in which patent is been applied for approval. The effective period for patent drug is mostly seven to twelve years, as a company applies for patent prior to clinical trials to assess drug safety. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing-insight/patent- medicine-market-4034 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Patent Medicine Market - Impact of COVID-19 Sudden difficult situation of COVID-19 pandemic is affecting industries across the world. However, several industries are trying to overcome the financial situation. COVID-19 has affected the research and development in some fields of pharmaceutical industry, whereas surgical pharmaceutical industry is experiencing significant growth in patent filing due to rise in research and development in masks, infra-red thermometers, diagnostic kits, and mechanical ventilators. Global Patent Medicine Market Restraints However, high cost of patent medicine as compared to generic medicine is expected to hamper growth of the patent medicine market. Generic medicine manufacturing companies incur less costs in developing generic medicines when compared to branded drug manufacturers. Moreover, majority of the pharmaceutical companies practise ‘Patent Ever-greening’, which means that they try to incur more revenue/profit by making minor changes in existing product using same base formula but different chemical structure formula and secure patent on it, thereby claiming it novel. Furthermore, patients in underdeveloped countries cannot afford patented medicines due to high cost. These factors are expected to restrain the global patent medicine market growth over the forecast period. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4034 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Patent Medicine Market - Competitive Landscape. Key players operating in the global patent medicine market include Pfizer Inc, Bristol-Myers Squibb, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A, Merck & Co., Inc., Roche Holding AG, Amgen Inc, and AbbVie Inc. Key Developments In 2015, Pfizer Inc. (New York, NY) and Merck Sharp & Dohme Corp. (Rahway, NJ) presented invention related to combination therapies useful for the treatment of cancer. In particular, the invention relates to a combination therapy, which comprises an antagonist of a Programmed Death 1 protein (PD-1) and an inhibitor of anaplastic lymphoma kinase (ALK). In April 2020, Otsuka Pharmaceutical Co., Ltd. (Tokyo) patented invention related to an injectable preparation comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H- quinolin-2-one or a salt, which has a wide therapeutic spectrum for central nervous system diseases (particularly schizophrenia) In June 2020, GlaxoSmithKline Biologicals SA patented invention related to immunogenic compositions such as vaccines, comprising immunogenic polypeptides from Haemophilus influenzae and Moraxella catarrhalis, which is used for boosting immune response. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4034 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. © Coherent market Insights. All Rights Reserved
KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved